Tin tức & Cập nhật
Xem bài viết Da liễu
Xem
Chỉ hiển thị Multimedia

Dupilumab improves AD symptoms in adult Asians
06 Jun 2026
bởiStephen Padilla
Treatment with dupilumab results in significant improvements in the signs and symptoms of moderate-to-severe atopic dermatitis (AD) in adult Asian patients without any serious adverse effects, a Singapore study has shown.
06 Jun 2026

Seladelpar delivers improvements in cholestatic biomarkers, pruritus in PBC patients
09 May 2026
bởiStephen Padilla
Treatment with seladelpar for up to 2 years improves cholestatic biomarkers and pruritus in patients with primary biliary cholangitis (PBC), with no serious safety concerns noted with long-term use, as shown by interim results of the ASSURE study.
09 May 2026

Ipilimumab plus nivolumab prolongs survival in melanoma with brain metastases
05 May 2026
bởiStephen Padilla
Treatment with ipilimumab plus nivolumab improves long-term survival in melanoma patients with asymptomatic brain metastases, according to the results of the NIBIT-M2 trial presented at AACR 2026.
05 May 2026





